Flurin Sturzenegger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Flurin Sturzenegger has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Joana Raquel Martins
Center for Microscopy and Image Analysis, University of Zurich, Zurich, Switzerland
2 shared publications - José María Mateos
Center for Microscopy and Image Analysis University of Zürich Zürich Switzerland
2 shared publications - Urs Ziegler
Center for Microscopy and Image Analysis, University of Zurich, Zurich, Switzerland
2 shared publications - Andrea Laimbacher
Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich
1 shared publication Andreas Schlitzer
Quantitative Systems Biology, Life and Medical Sciences Institute, University of Bonn, Bonn, Germany
1 shared publication- Andres Kaech
Center for Microscopy and Image Analysis, University of Zurich, Zurich, Switzerland
1 shared publication
Latest Publications
- 11 September 2026
- Published by EMBL-EBI
Chlamydia suis strains exhibit distinct developmental kinetics, coinfection dynamics and tetracycline responses associated with their phylogenetic clade
BioStudies – one package for all the data supporting a study
- 11 September 2026
- Published by EMBL-EBI
Chlamydia suis strains exhibit distinct developmental kinetics, coinfection dynamics and tetracycline responses associated with their phylogenetic clade
BioStudies – one package for all the data supporting a study
- Open Access
Compartmental Profiling of PDE4B in Systemic Sclerosis
The preferential phosphodiesterase 4B (PDE4B) inhibitor nerandomilast was recently approved for treatment of idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis. Its proposed immunomodulatory, anti-fibrotic, and endothelial-stabilising actions target all three cardinal features of SSc, yet PDE4B expression has not been systematically characterised in SSc tissue. We aimed to define PDE4B expression across fibrotic organs and cellular compartments in SSc. PDE4B expression was profiled in SSc lung, peripheral blood mononuclear cells (PBMCs) and skin on the transcript level using single-cell RNA sequencing data and on the protein level using immunohistochemistry, immunofluorescence and multiplexed immunofluorescent stainings. PDE4B was consistently dysregulated in immune cells across SSc tissue and PBMCs, with compartment-specific direction and distribution. In SSc-ILD lung, expression was increased in CD8⁺ and CD4⁺ memory T-cells. In PBMCs, expression was increased in B cells, monocytes, and CD8⁺ T-cells, and stratified patients into three endotypes (PDE4Bˡᵒ/ᵐᵉᵈ/hi) not distinguishable by clinical variables. In skin, bulk RNA-seq showed a significant global increase, which localized to myeloid cells in scRNA-seq data. Approximately 90% of FAP⁺ activated fibroblasts co-expressed PDE4B at the protein level in SSc skin, identifying the activated fibroblast compartment as a candidate target for PDE4B inhibition. No PDE4B dysregulation was detected in vascular cell types. This first cell-type-resolved characterisation of PDE4B in SSc demonstrates consistent immune-cell dysregulation across tissues and protein-level enrichment in activated fibroblasts. This provides a human-tissue rationale for the immunomodulatory and anti-fibrotic effects of PDE4B inhibition and supporting PDE4B as a disease-relevant therapeutic target in SSc.
Open AccessCompartmental Profiling of PDE4B in Systemic Sclerosis
The preferential phosphodiesterase 4B (PDE4B) inhibitor nerandomilast was recently approved for treatment of idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis. Its proposed immunomodulatory, anti-fibrotic, and endothelial-stabilising actions target all three cardinal features of SSc, yet PDE4B expression has not been systematically characterised in SSc tissue. We aimed to define PDE4B expression across fibrotic organs and cellular compartments in SSc. PDE4B expression was profiled in SSc lung, peripheral blood mononuclear cells (PBMCs) and skin on the transcript level using single-cell RNA sequencing data and on the protein level using immunohistochemistry, immunofluorescence and multiplexed immunofluorescent stainings. PDE4B was consistently dysregulated in immune cells across SSc tissue and PBMCs, with compartment-specific direction and distribution. In SSc-ILD lung, expression was increased in CD8⁺ and CD4⁺ memory T-cells. In PBMCs, expression was increased in B cells, monocytes, and CD8⁺ T-cells, and stratified patients into three endotypes (PDE4Bˡᵒ/ᵐᵉᵈ/hi) not distinguishable by clinical variables. In skin, bulk RNA-seq showed a significant global increase, which localized to myeloid cells in scRNA-seq data. Approximately 90% of FAP⁺ activated fibroblasts co-expressed PDE4B at the protein level in SSc skin, identifying the activated fibroblast compartment as a candidate target for PDE4B inhibition. No PDE4B dysregulation was detected in vascular cell types. This first cell-type-resolved characterisation of PDE4B in SSc demonstrates consistent immune-cell dysregulation across tissues and protein-level enrichment in activated fibroblasts. This provides a human-tissue rationale for the immunomodulatory and anti-fibrotic effects of PDE4B inhibition and supporting PDE4B as a disease-relevant therapeutic target in SSc.
- 22 July 2026
- Published by EMBL-EBI
Data associated with "Flexible workflows for small volume electron microscopy using resin and Tokuyasu sections"
BioStudies – one package for all the data supporting a study
- 22 July 2026
- Published by EMBL-EBI
Data associated with "Flexible workflows for small volume electron microscopy using resin and Tokuyasu sections"
BioStudies – one package for all the data supporting a study
- Open Access
- 1 September 2025
- Published by Springer Nature in Nature Chemical Biology
- Vol. 22 (3) , 369-378
Real-time visualization of STAT activation in live cells using genetically encoded biosensors
Signal transducer and activator of transcription (STAT) is a family of key transcriptional regulators in immune, epithelial and mesenchymal cells. Aberrant STAT activity is associated with malignancy, autoimmunity and immunodeficiency. The STAT signaling pathways are very attractive drug targets; however, validated tools to monitor real-time activation of STATs are lacking. Here, we developed a class of highly sensitive genetically encoded STAT biosensors, termed STATeLights, which allowed direct and continuous detection of STAT activity in live cells with high spatiotemporal resolution. Using human STAT5A, we demonstrate the versatility of STATeLight5A to quantify the activation of wild-type STAT5 versus disease-associated STAT5 mutants and to precisely select compounds targeting the STAT5 signaling pathway. Moreover, STATeLight5A also facilitated real-time tracking of STAT5 activation in human primary CD4 + T cells. Collectively, our biosensors open up unprecedented possibilities of studying STAT biology and druggability in various cellular contexts.
- 1 September 2025
- Published by Springer Nature in Nature Chemical Biology
- Vol. 22 (3) , 369-378
Open AccessReal-time visualization of STAT activation in live cells using genetically encoded biosensors
Signal transducer and activator of transcription (STAT) is a family of key transcriptional regulators in immune, epithelial and mesenchymal cells. Aberrant STAT activity is associated with malignancy, autoimmunity and immunodeficiency. The STAT signaling pathways are very attractive drug targets; however, validated tools to monitor real-time activation of STATs are lacking. Here, we developed a class of highly sensitive genetically encoded STAT biosensors, termed STATeLights, which allowed direct and continuous detection of STAT activity in live cells with high spatiotemporal resolution. Using human STAT5A, we demonstrate the versatility of STATeLight5A to quantify the activation of wild-type STAT5 versus disease-associated STAT5 mutants and to precisely select compounds targeting the STAT5 signaling pathway. Moreover, STATeLight5A also facilitated real-time tracking of STAT5 activation in human primary CD4 + T cells. Collectively, our biosensors open up unprecedented possibilities of studying STAT biology and druggability in various cellular contexts.
- 8 August 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 10 (110) , eadt0688
GM-CSF derived from alveolar type 2 cells promotes CD301b + cDC2 generation and allergic airway inflammation
Pulmonary conventional dendritic cells (cDCs) are functionally and phenotypically heterogeneous antigen-presenting cells essential for orchestrating adaptive immune responses in the lung. Here, we define a cell-intrinsic role for granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling in the development of a CD301b + subset of terminally differentiated cDC2s, in addition to CD103 + XCR1 + cDC1s. Unbiased single-cell transcriptomic profiling of CD11c + cells identified both immature and differentiated lung cDC populations. GM-CSF deficiency disrupted antiapoptotic Bcl2a1 up-regulation and impaired progression to the CD301b + transcriptional state. Despite the positioning of CD301b + cDC2s in lymphoid cell–rich adventitial cuff areas, hematopoietic GM-CSF was dispensable for their development. Instead, alveolar epithelial type 2 cell–derived GM-CSF was required for CD301b + cDC2 formation and pulmonary type 2 immune responses, highlighting the central role of GM-CSF signaling in shaping the pulmonary myeloid landscape.
- 8 August 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 10 (110) , eadt0688
GM-CSF derived from alveolar type 2 cells promotes CD301b + cDC2 generation and allergic airway inflammation
Pulmonary conventional dendritic cells (cDCs) are functionally and phenotypically heterogeneous antigen-presenting cells essential for orchestrating adaptive immune responses in the lung. Here, we define a cell-intrinsic role for granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling in the development of a CD301b + subset of terminally differentiated cDC2s, in addition to CD103 + XCR1 + cDC1s. Unbiased single-cell transcriptomic profiling of CD11c + cells identified both immature and differentiated lung cDC populations. GM-CSF deficiency disrupted antiapoptotic Bcl2a1 up-regulation and impaired progression to the CD301b + transcriptional state. Despite the positioning of CD301b + cDC2s in lymphoid cell–rich adventitial cuff areas, hematopoietic GM-CSF was dispensable for their development. Instead, alveolar epithelial type 2 cell–derived GM-CSF was required for CD301b + cDC2 formation and pulmonary type 2 immune responses, highlighting the central role of GM-CSF signaling in shaping the pulmonary myeloid landscape.
- 24 January 2024
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 146 (5) , 3539-3544
Single-Molecule FRET at 10 MHz Count Rates
A bottleneck in many studies utilizing single-molecule Förster resonance energy transfer is the attainable photon count rate, as it determines the temporal resolution of the experiment. As many biologically relevant processes occur on time scales that are hardly accessible with currently achievable photon count rates, there has been considerable effort to find strategies to increase the stability and brightness of fluorescent dyes. Here, we use DNA nanoantennas to drastically increase the achievable photon count rates and observe fast biomolecular dynamics in the small volume between two plasmonic nanoparticles. As a proof of concept, we observe the coupled folding and binding of two intrinsically disordered proteins, which form transient encounter complexes with lifetimes on the order of 100 μs. To test the limits of our approach, we also investigated the hybridization of a short single-stranded DNA to its complementary counterpart, revealing a transition path time of 17 μs at photon count rates of around 10 MHz, which is an order-of-magnitude improvement compared to the state of the art. Concomitantly, the photostability was increased, enabling many seconds long megahertz fluorescence time traces. Due to the modular nature of the DNA origami method, this platform can be adapted to a broad range of biomolecules, providing a promising approach to study previously unobservable ultrafast biophysical processes.
- 24 January 2024
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 146 (5) , 3539-3544
Single-Molecule FRET at 10 MHz Count Rates
A bottleneck in many studies utilizing single-molecule Förster resonance energy transfer is the attainable photon count rate, as it determines the temporal resolution of the experiment. As many biologically relevant processes occur on time scales that are hardly accessible with currently achievable photon count rates, there has been considerable effort to find strategies to increase the stability and brightness of fluorescent dyes. Here, we use DNA nanoantennas to drastically increase the achievable photon count rates and observe fast biomolecular dynamics in the small volume between two plasmonic nanoparticles. As a proof of concept, we observe the coupled folding and binding of two intrinsically disordered proteins, which form transient encounter complexes with lifetimes on the order of 100 μs. To test the limits of our approach, we also investigated the hybridization of a short single-stranded DNA to its complementary counterpart, revealing a transition path time of 17 μs at photon count rates of around 10 MHz, which is an order-of-magnitude improvement compared to the state of the art. Concomitantly, the photostability was increased, enabling many seconds long megahertz fluorescence time traces. Due to the modular nature of the DNA origami method, this platform can be adapted to a broad range of biomolecules, providing a promising approach to study previously unobservable ultrafast biophysical processes.